1. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection;Wilde;Drugs,1996
2. OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies;Transplant Proc,1995
3. Adverse events associated with OKT3 immunosuppression in the prevention or treatment of allograft rejection;Kreis;Clin Transplant,1993
4. General aspects of cytokine-release syndrome: timing and incidence of symptoms;Jeyarajah;Transplant Proc,1993
5. Low-dose OKT3 induction therapy following renal transplantation leads to improved graft function and decreased adverse effects;Brown;Transplant Proc,1993